结果公布-话题@MedSci

#结果公布#

126篇内容 | 3408人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2004405, encodeId=c257200440562, content=<a href='/topic/show?id=54ebe8621cf' target=_blank style='color:#2F92EE;'>#结果公布#</a>, objectTitle=2019 WCLC | 五年五倍! 全球NSCLC免疫治疗三期临床研究5年生存结果公布—CM017/057汇总分析, objectType=article, longId=179498, objectId=3c141e949899, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c141e949899, replyNumber=0, likeNumber=87, createdTime=2020-01-31, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c141e949899, moduleTitle=2019 WCLC | 五年五倍! 全球NSCLC免疫治疗三期临床研究5年生存结果公布—CM017/057汇总分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c141e949899)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2004398, encodeId=b6b42004398b4, content=<a href='/topic/show?id=54ebe8621cf' target=_blank style='color:#2F92EE;'>#结果公布#</a>, objectTitle=CSCO 2018 | 陆舜教授：CheckMate 078中国人群亚组分析结果公布，中国患者获益显著, objectType=article, longId=149441, objectId=26eb149441ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=26eb149441ba, replyNumber=0, likeNumber=86, createdTime=2019-07-19, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=26eb149441ba, moduleTitle=CSCO 2018 | 陆舜教授：CheckMate 078中国人群亚组分析结果公布，中国患者获益显著, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=26eb149441ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2004403, encodeId=4e752004403a8, content=<a href='/topic/show?id=54ebe8621cf' target=_blank style='color:#2F92EE;'>#结果公布#</a>, objectTitle=TransCon生长激素治疗儿童生长激素缺乏症三期临床研究核心结果公布, objectType=article, longId=161852, objectId=274016185262, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=274016185262, replyNumber=0, likeNumber=77, createdTime=2019-05-06, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=274016185262, moduleTitle=TransCon生长激素治疗儿童生长激素缺乏症三期临床研究核心结果公布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=274016185262)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2004404, encodeId=77a92004404bf, content=<a href='/topic/show?id=54ebe8621cf' target=_blank style='color:#2F92EE;'>#结果公布#</a>, objectTitle=Opdivo肺癌长期疗效结果公布，4年总生存达到14%, objectType=article, longId=163619, objectId=b284163619a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b284163619a1, replyNumber=0, likeNumber=68, createdTime=2019-12-17, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b284163619a1, moduleTitle=Opdivo肺癌长期疗效结果公布，4年总生存达到14%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b284163619a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2004390, encodeId=62302004390ec, content=<a href='/topic/show?id=54ebe8621cf' target=_blank style='color:#2F92EE;'>#结果公布#</a>, objectTitle=重磅！2018年度国家自然科学基金项目申请初审结果公布, objectType=article, longId=137234, objectId=d0fb13e234f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d0fb13e234f3, replyNumber=0, likeNumber=68, createdTime=2018-10-05, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d0fb13e234f3, moduleTitle=重磅！2018年度国家自然科学基金项目申请初审结果公布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d0fb13e234f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2004400, encodeId=720c2004400c1, content=<a href='/topic/show?id=54ebe8621cf' target=_blank style='color:#2F92EE;'>#结果公布#</a>, objectTitle=带量采购结果公布，过一致性评价药品命中率高，重点监控品种暂停交易, objectType=article, longId=153492, objectId=54f715349287, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=54f715349287, replyNumber=0, likeNumber=64, createdTime=2018-12-22, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=54f715349287, moduleTitle=带量采购结果公布，过一致性评价药品命中率高，重点监控品种暂停交易, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=54f715349287)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2004391, encodeId=3534200439101, content=<a href='/topic/show?id=54ebe8621cf' target=_blank style='color:#2F92EE;'>#结果公布#</a>, objectTitle=2018国家自然科学基金项目申请初审结果公布, objectType=article, longId=137244, objectId=626813e2448c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=626813e2448c, replyNumber=0, likeNumber=0, createdTime=2018-11-18, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=626813e2448c, moduleTitle=2018国家自然科学基金项目申请初审结果公布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=626813e2448c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2004402, encodeId=5cc2200440200, content=<a href='/topic/show?id=54ebe8621cf' target=_blank style='color:#2F92EE;'>#结果公布#</a>, objectTitle="基因编辑婴儿事件"初步调查结果公布, objectType=article, longId=158584, objectId=728615858482, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=728615858482, replyNumber=0, likeNumber=76, createdTime=2019-11-10, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=728615858482, moduleTitle="基因编辑婴儿事件"初步调查结果公布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=728615858482)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2004395, encodeId=37122004395a2, content=<a href='/topic/show?id=54ebe8621cf' target=_blank style='color:#2F92EE;'>#结果公布#</a>, objectTitle=北京基层医疗考核结果公布社区门急诊量增长近两成, objectType=article, longId=140250, objectId=0acf14025082, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0acf14025082, replyNumber=0, likeNumber=31, createdTime=2018-09-08, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0acf14025082, moduleTitle=北京基层医疗考核结果公布社区门急诊量增长近两成, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0acf14025082)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2004401, encodeId=7797200440193, content=<a href='/topic/show?id=54ebe8621cf' target=_blank style='color:#2F92EE;'>#结果公布#</a>, objectTitle=JCO：洛莫司汀联合化疗改善老年AML患者的生存？LAM-SA 2007全新结果公布, objectType=article, longId=154054, objectId=68de15405428, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=68de15405428, replyNumber=0, likeNumber=0, createdTime=2019-04-14, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=68de15405428, moduleTitle=JCO：洛莫司汀联合化疗改善老年AML患者的生存？LAM-SA 2007全新结果公布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=68de15405428)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2004399, encodeId=7cc6200439972, content=<a href='/topic/show?id=54ebe8621cf' target=_blank style='color:#2F92EE;'>#结果公布#</a>, objectTitle=2018 WCLC | 张力教授：Keynote－032结果公布，Keynote－033值得期待, objectType=article, longId=150100, objectId=a38a150100d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a38a150100d9, replyNumber=0, likeNumber=61, createdTime=2019-02-20, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a38a150100d9, moduleTitle=2018 WCLC | 张力教授：Keynote－032结果公布，Keynote－033值得期待, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a38a150100d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2004387, encodeId=ada9200438e3f, content=<a href='/topic/show?id=54ebe8621cf' target=_blank style='color:#2F92EE;'>#结果公布#</a>, objectTitle=【AHA 2017】重要实验结果公布：Anacetrapib对新发糖尿病发病及糖尿病患者血管事件的影响, objectType=article, longId=120663, objectId=c2811206633c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c2811206633c, replyNumber=0, likeNumber=69, createdTime=2017-12-21, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c2811206633c, moduleTitle=【AHA 2017】重要实验结果公布：Anacetrapib对新发糖尿病发病及糖尿病患者血管事件的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c2811206633c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2004385, encodeId=1b9f2004385c4, content=<a href='/topic/show?id=54ebe8621cf' target=_blank style='color:#2F92EE;'>#结果公布#</a>, objectTitle=【WCLC 2017】FLAURA研究伴随诊断结果公布：血浆EGFR突变阳性与组织阳性患者接受奥希替尼一线治疗获益一致, objectType=article, longId=116656, objectId=7181116656ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7181116656ed, replyNumber=0, likeNumber=70, createdTime=2018-07-18, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7181116656ed, moduleTitle=【WCLC 2017】FLAURA研究伴随诊断结果公布：血浆EGFR突变阳性与组织阳性患者接受奥希替尼一线治疗获益一致, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7181116656ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2004397, encodeId=3cd4200439e30, content=<a href='/topic/show?id=54ebe8621cf' target=_blank style='color:#2F92EE;'>#结果公布#</a>, objectTitle=2018年度国自然基金结果公布了！, objectType=article, longId=146770, objectId=69e1146e7007, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=69e1146e7007, replyNumber=0, likeNumber=79, createdTime=2019-06-15, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=69e1146e7007, moduleTitle=2018年度国自然基金结果公布了！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=69e1146e7007)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2004394, encodeId=aea72004394ac, content=<a href='/topic/show?id=54ebe8621cf' target=_blank style='color:#2F92EE;'>#结果公布#</a>, objectTitle=2017年度互联互通测评结果公布山东省斩获双冠军, objectType=article, longId=138838, objectId=6ad813883822, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ad813883822, replyNumber=0, likeNumber=78, createdTime=2018-09-11, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ad813883822, moduleTitle=2017年度互联互通测评结果公布山东省斩获双冠军, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6ad813883822)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2004392, encodeId=15c12004392b5, content=<a href='/topic/show?id=54ebe8621cf' target=_blank style='color:#2F92EE;'>#结果公布#</a>, objectTitle=Blood：伊布替尼单药治疗慢性淋巴细胞白血病5年随访结果公布！, objectType=article, longId=137617, objectId=231413e617e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=231413e617e4, replyNumber=0, likeNumber=63, createdTime=2019-02-06, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=231413e617e4, moduleTitle=Blood：伊布替尼单药治疗慢性淋巴细胞白血病5年随访结果公布！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=231413e617e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2004396, encodeId=1b6120043963f, content=<a href='/topic/show?id=54ebe8621cf' target=_blank style='color:#2F92EE;'>#结果公布#</a>, objectTitle=家庭医生签约服务调查结果公布北京居民这样说, objectType=article, longId=141700, objectId=6c48141e00a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6c48141e00a3, replyNumber=0, likeNumber=32, createdTime=2018-08-25, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6c48141e00a3, moduleTitle=家庭医生签约服务调查结果公布北京居民这样说, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6c48141e00a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2004393, encodeId=f7ea20043936c, content=<a href='/topic/show?id=54ebe8621cf' target=_blank style='color:#2F92EE;'>#结果公布#</a>, objectTitle=【2018ASCO抢先看】慢性期慢性粒细胞白血病停用二线尼罗替尼治疗144周的结果公布(ABS:7003), objectType=article, longId=138593, objectId=a18d13859331, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a18d13859331, replyNumber=0, likeNumber=76, createdTime=2019-02-07, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a18d13859331, moduleTitle=【2018ASCO抢先看】慢性期慢性粒细胞白血病停用二线尼罗替尼治疗144周的结果公布(ABS:7003), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a18d13859331)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2004382, encodeId=453320043825f, content=<a href='/topic/show?id=54ebe8621cf' target=_blank style='color:#2F92EE;'>#结果公布#</a>, objectTitle=【ESC 2017】CAPTAF研究结果公布, objectType=article, longId=111269, objectId=a951111269ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a951111269ba, replyNumber=0, likeNumber=83, createdTime=2018-01-15, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a951111269ba, moduleTitle=【ESC 2017】CAPTAF研究结果公布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a951111269ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2004383, encodeId=ad9d20043832c, content=<a href='/topic/show?id=54ebe8621cf' target=_blank style='color:#2F92EE;'>#结果公布#</a>, objectTitle=【ESC 2017】EMPATHY结果公布, objectType=article, longId=111546, objectId=e58d1115466c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e58d1115466c, replyNumber=0, likeNumber=87, createdTime=2017-09-25, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e58d1115466c, moduleTitle=【ESC 2017】EMPATHY结果公布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e58d1115466c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

结果公布

2020-05-29

shanyongle (审核中...)

前往app查看评论内容

#结果公布#

2019 WCLC | 五年五倍! 全球NSCLC免疫治疗三期临床研究5年生存结果公布—CM017/057汇总分析

2020-01-31

shanyongle (审核中...)

前往app查看评论内容

#结果公布#

CSCO 2018 | 陆舜教授：CheckMate 078中国人群亚组分析结果公布，中国患者获益显著

2019-07-19

shanyongle (审核中...)

前往app查看评论内容

#结果公布#

TransCon生长激素治疗儿童生长激素缺乏症三期临床研究核心结果公布

2019-05-06

shanyongle (审核中...)

前往app查看评论内容

#结果公布#

Opdivo肺癌长期疗效结果公布，4年总生存达到14%

2019-12-17

shanyongle (审核中...)

前往app查看评论内容

#结果公布#

重磅！2018年度国家自然科学基金项目申请初审结果公布

2018-10-05

shanyongle (审核中...)

前往app查看评论内容

#结果公布#

带量采购结果公布，过一致性评价药品命中率高，重点监控品种暂停交易

2018-12-22

shanyongle (审核中...)

前往app查看评论内容

#结果公布#

2018国家自然科学基金项目申请初审结果公布

2018-11-18

shanyongle (审核中...)

前往app查看评论内容

#结果公布#

"基因编辑婴儿事件"初步调查结果公布

2019-11-10

shanyongle (审核中...)

前往app查看评论内容

#结果公布#

北京基层医疗考核结果公布社区门急诊量增长近两成

2018-09-08

shanyongle (审核中...)

前往app查看评论内容

#结果公布#

JCO：洛莫司汀联合化疗改善老年AML患者的生存？LAM-SA 2007全新结果公布

2019-04-14

shanyongle (审核中...)

前往app查看评论内容

#结果公布#

2018 WCLC | 张力教授：Keynote－032结果公布，Keynote－033值得期待

2019-02-20

shanyongle (审核中...)

前往app查看评论内容

#结果公布#

【AHA 2017】重要实验结果公布：Anacetrapib对新发糖尿病发病及糖尿病患者血管事件的影响

2017-12-21

shanyongle (审核中...)

前往app查看评论内容

#结果公布#

【WCLC 2017】FLAURA研究伴随诊断结果公布：血浆EGFR突变阳性与组织阳性患者接受奥希替尼一线治疗获益一致

2018-07-18

shanyongle (审核中...)

前往app查看评论内容

#结果公布#

2018年度国自然基金结果公布了！

2019-06-15

shanyongle (审核中...)

前往app查看评论内容

#结果公布#

2017年度互联互通测评结果公布山东省斩获双冠军

2018-09-11

shanyongle (审核中...)

前往app查看评论内容

#结果公布#

Blood：伊布替尼单药治疗慢性淋巴细胞白血病5年随访结果公布！

2019-02-06

智者为医08 (审核中...)

前往app查看评论内容

#结果公布#

家庭医生签约服务调查结果公布北京居民这样说

2018-08-25

shanyongle (审核中...)

前往app查看评论内容

#结果公布#

【2018ASCO抢先看】慢性期慢性粒细胞白血病停用二线尼罗替尼治疗144周的结果公布(ABS:7003)

2019-02-07

shanyongle (审核中...)

前往app查看评论内容

#结果公布#

【ESC 2017】CAPTAF研究结果公布

2018-01-15

shanyongle (审核中...)

前往app查看评论内容

#结果公布#

【ESC 2017】EMPATHY结果公布

2017-09-25

科室
- - 订阅+
  - 更多科室
工具
服务